Effect of recombinant human endostatin onradiotherapy for esophagus cancer

Author: Gao-Feng LIU ¹ ; Hui CHANG ¹ ; Bao-Tian LI ¹ ; Yong ZHANG ¹ ; Dan-Dan LI ¹ ; Yan LIU ¹ ; Yang YANG ²
Author Information

1. Department of Thoracic Surgery, No. 153 Hospital of Liberation Army
2. Department of Cardiothoracic Surgery, Xiangya Hospital Central-South University
Publication Type:Journal Article
Keywords: Esophageal cancer; Nudemice; Radiotherapy; Recombinant human endostatin; Vascular endothelial growth factor
From: Asian Pacific Journal of Tropical Medicine 2016;9(1):86-90
CountryChina
Language:Chinese
Abstract: Objective: To investigate the effect of radiotherapy plus recombinant human endostatin (RH-endostatin) on esophageal cancer and its mechanism. Methods: A total of 50 nudemice were equally randomized into control group, radiotherapy group, and combined therapy group I, II, and III after inoculating with Eca109 cell suspension (1 × 10